Vanguard Group Inc Eyenovia, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Eyenovia, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 438,313 shares of EYEN stock, worth $810,879. This represents 0.0% of its overall portfolio holdings.

Number of Shares

438,313

Previous 1,881,290 76.7%

Holding current value

$810,879

Previous $978,000 93.35%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$0.08 - $0.57 $115,438 - $822,496	-1,442,977 Reduced 76.7%	438,313 $65,000
Q2 2024 Aug 13, 2024	BUY	$0.52 - $1.06 $47,210 - $96,236	90,789 Added 5.07%	1,881,290 $1.11 Million
Q1 2024 May 10, 2024	BUY	$0.99 - $2.37 $357,314 - $855,389	360,924 Added 25.25%	1,790,501 $1.77 Million
Q4 2023 Feb 14, 2024	BUY	$1.08 - $2.08 $66,670 - $128,402	61,732 Added 4.51%	1,429,577 $2.97 Million
Q3 2023 Nov 14, 2023	BUY	$1.57 - $2.54 $66,849 - $108,150	42,579 Added 3.21%	1,367,845 $2.27 Million
Q2 2023 Aug 14, 2023	BUY	$2.21 - $5.75 $714,176 - $1.86 Million	323,157 Added 32.25%	1,325,266 $3.14 Million
Q1 2023 May 15, 2023	BUY	$1.72 - $3.53 $142,393 - $292,238	82,787 Added 9.01%	1,002,109 $3.54 Million
Q4 2022 Feb 10, 2023	SELL	$1.54 - $2.74 $12,986 - $23,106	-8,433 Reduced 0.91%	919,322 $1.5 Million
Q1 2022 May 13, 2022	SELL	$2.66 - $3.99 $8,025 - $12,037	-3,017 Reduced 0.32%	927,755 $2.83 Million
Q4 2021 Feb 14, 2022	BUY	$3.5 - $6.58 $690,392 - $1.3 Million	197,255 Added 26.89%	930,772 $3.72 Million
Q2 2021 Aug 13, 2021	BUY	$4.36 - $5.75 $3.2 Million - $4.22 Million	733,517 New	733,517 $3.64 Million

Others Institutions Holding EYEN

# of Institutions

Shares Held

12M

Call Options Held

13.1K

Put Options Held

21.3K

View Full List

About EYENOVIA, INC.

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $63.3M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

More about EYEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Eyenovia, Inc. Transaction History